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The pruned gene encodes the Drosophila serum response factor
and regulates cytoplasmic outgrowth during terminal branching
of the tracheal system
Abstract
We identified a Drosophila gene, pruned, that regulates formation of the terminal branches of the
tracheal (respiratory) system. These branches arise by extension of long cytoplasmic processes from
terminal tracheal cells towards oxygen-starved tissues, followed by formation of a lumen within the
processes. The pruned gene is expressed in terminal cells throughout the period of terminal branching.
pruned encodes the Drosophila homologue of serum response factor (SRF), which functions with an
ETS domain ternary complex factor as a growth-factor-activated transcription complex in mammalian
cells. In pruned loss of function mutants, terminal cells fail to extend cytoplasmic projections. A
constitutively activated SRF drives formation of extra projections that grow out in an unregulated
fashion. An activated ternary complex factor has a similar effect. We propose that the Drosophila SRF
functions like mammalian SRF in an inducible transcription complex, and that activation of this
complex by signals from target tissues induces expression of genes involved in cytoplasmic outgrowth.
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formation of the terminal branches of the tracheal (respi-
ratory) system. These branches arise by extension of long
cytoplasmic processes from terminal tracheal cells towards
oxygen-starved tissues, followed by formation of a lumen
within the processes. The pruned gene is expressed in
terminal cells throughout the period of terminal branching.
pruned encodes the Drosophila homologue of serum
response factor (SRF), which functions with an ETS
domain ternary complex factor as a growth-factor-
activated transcription complex in mammalian cells. In
pruned loss of function mutants, terminal cells fail to extend
cytoplasmic projections. A constitutively activated SRF
drives formation of extra projections that grow out in an
unregulated fashion. An activated ternary complex factor
has a similar effect. We propose that the Drosophila SRF
functions like mammalian SRF in an inducible transcrip-
tion complex, and that activation of this complex by signals
from target tissues induces expression of genes involved in
cytoplasmic outgrowth.
Key words: branching morphogenesis, tracheal development,
cytoplasmic outgrowth, serum response factor, Drosophila, pruned
SUMMARYINTRODUCTION
A general problem for all animals is the supply of oxygen to
internal tissues. The common structural solution is formation
of a branched tubular network that transports air or oxygenated
blood to the sites of utilization. In both the mammalian circu-
latory system and the insect tracheal (respiratory) system, fine
branches ramify on or near the oxygen-requiring tissues, with
the extent of branching matched to the oxygen needs of the
tissue. Angiogenesis has been intensively studied, and a
number of angiogenic factors have been identified in cell
culture assays, such as acidic and basic fibroblast growth
factors and vascular endothelial growth factor (Folkman and
Shing, 1992). It is not yet known how these signaling
molecules are involved in angiogenesis in vivo or how such
signals are transduced into capillary sprouting and growth
toward target tissues.
We have initiated a study of tracheal terminal branch
(tracheole) formation in Drosophila melanogaster, where the
branching process can be analyzed at cellular resolution and
dissected genetically. Tracheal tubes are a monolayer epithe-
lium that forms an elaborate tubular network with branches to
all body tissues (Rühle, 1932; Manning and Krasnow, 1993).Terminal branches contact the tissues, with most cells lying
close to or directly contacted by fine branches (Samakovlis et
al., 1996). Oxygen enters the tracheal network through the
spiracular openings and diffuses along the primary and
secondary branches and finally into the blind-ended terminal
branches, where it passes across the tracheal epithelium into
surrounding tissues.
Terminal branch formation is distinguished from other
tracheal branching events by its cellular mechanism and
patterns of outgrowth. Terminal branches arise from individ-
ual tracheal cells (called terminal cells) as long cytoplasmic
extensions that resemble neuronal processes (Keister, 1948;
Wigglesworth, 1972; Samakovlis et al., 1996). The extensions
grow towards tracheal target tissues, often reaching 100 m m or
more in length. The extensions form a lumen in their
cytoplasm, thus becoming fine tubules capable of oxygen
transport. The extent and pattern of terminal branching, unlike
the earlier stages of branching, is not stereotyped (Rühle,
1932). It is regulated during development by tissue oxygen
need, so that tissues with greater need receive a denser supply
of branches.
In this paper we report the identification of a gene, pruned,
that is required for terminal branch formation. Molecular char-
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Fig. 1. The pruned lacZ enhancer trap marker is expressed in all
tracheal terminal cells. (A) Diagram of left side of tracheal system of
a stage 15 embryo stained with a lumen-specific antibody (mAb
2A12). The first, fifth and tenth tracheal hemisegments (Tr1, Tr5,
Tr10) are indicated. Dorsal is top and anterior is left in this and all
other figures. (B-D) Typical nuclear positions (filled circles) of lacZ
(b -galactosidase)-expressing cells in Tr1 (B), Tr5 (C), and Tr10 (D)
of stage 15 embryos carrying the pruned1 marker. The expressing
cells are called terminal cells and give rise to terminal branches. The
major tracheal branches from which the terminal branches shown in
E- N arise are labeled (PB, pharyngeal branch; DB, dorsal branch;
VB, visceral branch; LT, lateral trunk; and GB, ganglionic branch),
along with the dorsal trunk (DT) and the dorsal anastomosis (DA)
which connects to the contralateral hemisegment. (E-I) Light
micrographs of selected b -galactosidase-expressing cells at stage 15,
with terminal cell nuclei stained brown (b -galactosidase) and the
tracheal lumen stained black (mAb 2A12). The lumen does not
extend beyond the terminal cell nuclei at this stage. Only two lateral
trunk terminal cells are clearly visible in H. (J-N) b -galactosidase-
expressing cells as in E-I but at stage 17. Note lumenal extensions
(arrowheads) distal to the nuclei, which are the first terminal
branches to form in each cell. Occasionally, a cell has formed more
than one branch at this stage (top two arrowheads in M). The
terminal visceral branches are still very short at stage 17 (L,
arrowhead), but like other terminal branches they ramify extensively
during the larval period (see R-T). (O-Q) Transverse sections of a
stage 17 embryo showing intimate contact between terminal
branches and target tissues. Tracheal cells are stained brown (1-eve-1
marker). Terminal cell nuclei are indicated by arrows and
cytoplasmic extensions by arrowheads. A dorsal branch terminal cell
(DB1) extends a terminal branch along the dorsal epidermis (DE) in
O. A visceral branch terminal cell extends a terminal branch along
the visceral mesoderm (VM) in P. A terminal cell from the lateral
trunk extends a terminal branch along a somatic muscle (SM) in Q.
(R-T) Ramification of a visceral branch terminal cell on the gut in a
third instar larva. R is a phase contrast image in which the air-filled
terminal branches appear as thin dark curves. S is a fluorescence
micrograph of the same field showing DAPI-stained nuclei. T is a
composite tracing of R and S. The secondary tracheal branch is
cross-hatched and its terminal branches are shown as thin solid lines;
the terminal cell nucleus (dark grey fill) is located near the point
where the branch begins to ramify. The nuclei of the larval and
imaginal gut cells are shown as large and small circles (in light grey
fill), respectively. (U) Light micrograph of a visceral tracheal branch
from a heterozygous pruned1 third instar larva showing continued
expression of b -galactosidase in the terminal cell nucleus. Fine
branches were lost during fixation and staining. Bars in I (for E-N),
Q (for O-Q), R (for R-T) and U, 10 m m.acterization shows that it encodes the Drosophila homologue
of mammalian serum response factor (SRF) and that it is
specifically expressed in terminal cells during terminal
branching. SRF has been intensively studied in cultured
mammalian cells where it functions with ternary complex
factors in growth-factor-activated transcription complexes that
regulate expression of c-fos and other cellular immediate early
genes, and also is involved in muscle-specific gene expression
(reviewed by Treisman, 1994, 1995). Although SRF is
involved in transduction of a variety of extracellular signals in
cultured cells, its function in animals is unknown. We show
that the critical role of SRF in early Drosophila development
is to regulate cytoplasmic outgrowth during terminal
branching. The results suggest that the Drosophila and
mammalian proteins are functional homologues, and that the
Drosophila protein functions like mammalian SRF in an
inducible transcription complex. We propose that activation of
this complex by signals from tracheal target tissues stimulates
expression of genes involved in cytoplasmic outgrowth.
MATERIALS AND METHODS
Fly strains and genetics
The pruned1 allele was isolated in a screen for tracheal enhancer trap
lines (Terminal-1; Samakovlis et al., 1996). It carries a P[lacZ, rosy+]
element and corresponds to strain l(2)3267 of the Spradling collec-
tion (Spradling et al., 1995). Additional alleles and revertants were
created by excision of the P element, after crossing in a third chro-
mosome carrying D 2-3 to supply transposase. Eighty-five rosy- males
from independent excision events were isolated and used to establish
stocks. Excision alleles used here were: prunedex84 (early pupal lethal,
severe tracheal phenotype); prunedex53 and prunedex87 (lethal as
pharate adults, intermediate tracheal phenotype); prunedex3,
prunedex8,and prunedex40 (viable revertants, no tracheal phenotype).
CyO balancer chromosomes carrying P[hunchback-lacZ, rosy+] or
P[fushi tarazu-lacZ, rosy+], and chromosome translocation TSTL14
carrying the Tubby mutation were used to distinguish heterozygous
pruned embryos and larvae from homozygotes. Chromosome defi-
ciencies Px4, Px and Px2 have been described (Kimble et al., 1990).
(The tracheal phenotypes previously reported for these deficiencies
(Kimble et al., 1990; Affolter et al., 1994), in which primary tracheal
branches are disrupted and discontinuous, are due to the deletion of
another gene or more than one gene in the region.) Canton-S was the
wild-type strain. Other lacZ enhancer trap lines were the general
tracheal markers 1-eve-1 (Perrimon et al., 1991) and 6-81a (Bier et
al., 1989), and terminal cell markers Terminal-2 to 5 (Samakovlis et
al., 1996).
Histology and immunohistochemistry
Embryos were fixed and immunostained as described (Samakovlis et
al., 1996). Rat polyclonal serum against the Drosophila SRF (Affolter
et al., 1994) was used at 1:300 dilution. mAb FMM5 against muscle
myosin (from D. Kiehart and C. Goodman) was used at a 1:5 dilution.
Other tracheal antibodies are described elsewhere (Samakovlis et al.,
1996). Embryo staging was according to Campos-Ortega and Harten-
stein (1985).
To visualize tracheal cells in sectioned embryos, embryos het-
erozygous for the 1-eve-1 enhancer trap marker were fixed in 4%
formaldehyde and 0.5% glutaraldehyde. After immunostaining for b -
galactosidase, individual embryos, staged under a dissecting micro-
scope by their tracheal and gut morphology, were dehydrated through
an ethanol series, infiltrated overnight with Epon-Araldite, and
embedded in fresh resin in flat embedding molds. Blocks werehardened for 48 hours at 70°C. Sections (5 m m thick) were cut on a
Reichard ultramicrotome, counterstained with 1% methylene blue,
and mounted on microscope slides with Permount. 
Larvae were dissected in phosphate-buffered saline and fixed in
either 1% glutaraldehyde or 2% formaldehyde for 4¢ ,6¢ diamidino-2-
phenylindole (DAPI) staining or horseradish peroxidase immunocy-
tochemistry, respectively, as described by Talbot et al. (1993).
Trachea of live larvae were examined under phase contrast optics after
anesthetization with sodium azide and mounting in halocarbon oil.
Expression of SRF and Elk-1 derivatives
Flies carrying the activated SRF or Elk-1 constructs described below
were crossed to flies carrying a tracheal Gal4p expression construct,
and the resulting embryos were aged at 29˚C for maximal Gal4p
activity (Brand et al., 1994). Late stage embryos were fixed and
stained for tracheal antigens. The C38 (Lin and Goodman, 1994) and
Tracheal GAL4 (A. Brand, personal communication) lines both
1355DSRF regulates cytoplasmic outgrowthexpress Gal4p in all tracheal cells beginning at the end of stage 12,
as assayed with a UAS:lacZ construct, and both gave very similar
results with all UAS constructs. Experiments with dominant negative
Elk-1 were carried out in a similar fashion except that embryos were
reared at 18˚C. This reduces Gal4p activity (Brand et al., 1994) and
it reduced the penetrance of early tracheal defects that were also seenPBTr 1 Tr 5 Tr 10
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17with dominant negative Elk-1. Apparently, ternary complex factor
plays a role earlier in tracheal development, but the function in
terminal branching is more sensitive to dominant negative Elk-1.
The structure of the constitutively active SRF-VP16 fusion gene
(Dalton and Treisman, 1992), the constitutively active Elk-1-VP16
gene (Hill et al., 1994), and the dominant negative Elk-1 gene (HillVB
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Fig. 2. Terminal branches are truncated in pruned embryos and
larvae. The dorsal branch (A,B) and end of a pharyngeal branch
(C,D) in stage 17 heterozygous pruned1 embryos (A,C) and
homozygous pruned1 embryos of the same age (B,D), stained for
tracheal lumen (mAb 2A12). Arrowheads show the ends of normal
and truncated terminal branches. (E,F) Left and right dorsal branches
of wild-type (E) and pruned1 homozygous (F) third instar larva in
dorsal view. In the mutant, the dorsal branches end prematurely
(arrowhead in F) and without ramification, near the point where the
dorsal branch ramifies extensively in wild type (arrowhead in E). The
proximal portion of the dorsal branches (DB) and the dorsal
anastomosis (DA) connecting the right and left dorsal branches are
unaffected in the mutant. Bars in D (for A-D) and E (for E-F),
10 m m.et al., 1993) have been described. Each was subcloned into the P
element vector pUAST (Brand and Perrimon, 1993) downstream of
the Gal4p UAS, and germ-line transformants were generated
(Spradling and Rubin, 1982). At least two independent transformants
of each construct were tested and gave similar results.
Molecular biology
Genomic DNA flanking the pruned1 P element was isolated by
plasmid rescue in E. coli (Pirotta, 1986). Flanking genomic DNA
(approx. 15 kb) was recovered from an SpeI digest of genomic DNA,
and 1.4 kb extending upstream of the pruned transcription unit were
recovered from an XbaI digest. For Southern blots (Fig. 5), a l DashII
(Stratagene) phage clone (DSRFØ2) containing 15 kb of genomic
DNA and a 2.2 kb DSRF cDNA (Affolter et al., 1994) were digested
separately with EcoRI and HindIII and hybridized with XbaI and SpeI
rescue plasmid probes. The sequence of the junctions between P
element and genomic DNA in the rescue plasmids was determined by
dideoxy sequencing, as was the corresponding region of the wild-type
chromosome from DSRFØ2.
RESULTS
The pruned marker is expressed in all terminal
tracheal cells throughout the period of terminal
branching
The pruned1 mutation was isolated in a screen of D.
melanogaster enhancer trap strains carrying a lacZ (b -galac-
tosidase) P element transposon at random genomic positions
(Samakovlis et al., 1996). The strain was identified by its
highly specific pattern of b -galactosidase expression in the
developing tracheal system. Tracheal hemisegments schema-
tized in Fig. 1B-D show the nuclear positions of b -galactosi-
dase-expressing cells in a pruned1 heterozygote at stage 15,
when primary and secondary branches have formed. Each
expressing cell gives rise to terminal branches, and all are
affected in pruned mutants (see below). Our description will
concentrate on the tracheal cells and branches shown at stage
15 in Fig. 1E-I. Fig. 1J-N shows the cells approx. 5 hours later
when each has begun to form its first terminal branch. These
terminal extensions contact different target tissues (Fig. 1O-
Q). In the larval period terminal cells continue to grow and
ramify on the target tissues (Samakovlis et al., 1996; Fig. 1R-
T). The pruned1 marker continues to be expressed in terminal
cells during this time (Fig. 1U).
Terminal branches are missing in pruned mutants
In homozygous pruned1 embryos, major tracheal branches and
connections between branches were almost always normal but
terminal branches were truncated or absent, giving the tracheal
tree a ‘pruned’ appearance. pruned1 is a recessive mutation and
the phenotype is fully penetrant. The embryonic phenotype
was most easily appreciated in the dorsal and ganglionic
branches (Figs 2A,B and 4B,C below), where terminal exten-
sions are normally very long at this stage, but other terminal
branches were similarly affected (Fig. 2C,D). Essentially every
terminal branch was severely truncated or absent in mutant
embryos.
When pruned1 was tested over Df(2R)Px4, which removes
a large chromosomal region including the pruned1 locus, the
hemizygous embryos exhibited the same tracheal phenotype
with the same penetrance and expressivity as pruned1 homozy-gotes. The same phenotype was also observed for strong
excision alleles of the pruned1 P element, for two strong EMS
alleles, and for small chromosomal deficiencies that remove
the pruned gene (see below; J. Montagne, J. G and M. A.,
unpublished data). Thus pruned1 is a loss of function allele,
and it represents the null condition for this function.
pruned1 is homozygous lethal with poor larval viability and
no survivors beyond the early pupal stage. Examination of
surviving larvae revealed a striking phenotype. Instead of the
extensive networks of terminal branches seen in wild type (see
Figs 1R-T and 2E), the parental branches of homozygous
pruned1 larvae ended abruptly without ramification (Fig. 2F).
The parental branches and branches that interconnect the
tracheal network were generally intact (DB and DA in Fig. 2F).
Thus the pruned1 mutation prevents formation of terminal
branches during both embryonic and larval periods. 
Despite the absence of terminal branches, the surviving
mutant larvae were still able to move about, although they were
more sluggish than their heterozygous siblings. Many mutant
larvae contained dark tissue masses typically associated with
the fat body. These might be necrotic fat body tissue resulting
from inadequate oxygen supply (see Abrahamson and Fanale,
1959).
1357DSRF regulates cytoplasmic outgrowthAbsence of terminal branches results from failure of
tracheal cells to extend cytoplasmic processes
The cellular events leading to formation of a terminal branch
in wild type are shown in Fig. 3A-D. At early stage 15, the
terminal cell begins to extend a cytoplasmic process (Fig. 3B,
arrowhead). A lumen is present in the terminal cell but only up
to the level of the nucleus (Fig. 3B,C); this is a secondary
tracheal branch. The cytoplasmic projection continues to grow,
becoming very thin as it extends along the surface of the target
(Fig. 3C,D). A lumen begins to form in the projection.
Lumenal staining appears in short patches at variable positions,
initially discontinuous with the lumen of the secondary branch
(arrowhead in Fig. 3C). Patches expand and coalesce, forming
a continuous lumen extending out to the tip of the projection
(Fig. 3D). During the larval period many more cytoplasmic
processes grow out and develop lumens, generating multiply-
branched cellular structures like the one shown in Fig. 1R-T.
The terminal cells of pruned1 embryos did not have long
cytoplasmic projections beyond the cell body (compare Fig. 3E
and G with D and F). In some cases rudimentary projections
were seen, but these were always short and broad, resembling
those in the wild type at early stage 15, and they never
supported a lumen. Thus, the absence of terminal branches in
pruned1 embryos is a consequence of the failure of terminal
cells to extend long cytoplasmic projections to their targets.
Defects in cytoplasmic outgrowth in pruned1 mutants were
detectable several hours after initiation of pruned gene
expression and only after terminal cells had migrated close to
their targets. Using tracheal cytoplasmic (1-eve-1), nuclear (6-
81a), and lumenal markers (mAb 2A12), we showed that
tracheal cell migration and lumen formation during earlier
branching events were little affected by the pruned1 mutation.
We also tested whether pruned was required for expression of
four terminal-cell-specific enhancer trap markers (Terminal-2
to 5), all of which are first expressed at or shortly after initiation
of pruned expression but before outgrowth of cytoplasmic
processes (Samakovlis et al., 1996). None of these markers
exhibited altered expression patterns in embryos homozygous
for prunedex84, a null allele of pruned that does not express
lacZ (data not shown). Thus, the earliest cellular or molecular
defect manifest in pruned embryos is the inability of terminal
cells to extend cytoplasmic processes to target tissues. 
The pruned gene encodes the Drosophila serum
response factor 
To begin molecular characterization of the pruned locus, we
first established that the tracheal phenotype and lethality of the
pruned1 mutation were due to the P element. Excision of the
P element, which carries a rosy+ marker, was induced by intro-
duction of a source of transposase. Twenty-one per cent (18 of
85) of the independent rosy - strains generated by excision were
fully viable, and the tracheal phenotype was reverted in all
three strains examined. Thus, the pruned1 lethality and tracheal
phenotype are caused by the P element. Among the lethal rosy-
strains obtained, several had tracheal phenotypes identical to
pruned1, including prunedex84 which lacked all b -galactosidase
expression. Other excision alleles (see Materials and Methods)
had less expressive phenotypes, with less severe truncations of
terminal branches.
The P element in pruned1 mapped to cytological position60C. This is the same chromosomal region as the recently
isolated homologue of mammalian serum response factor
(Affolter et al., 1994). The Drosophila serum response factor
(DSRF) is strongly expressed in a subset of embryonic tracheal
cells, and more weakly in somatic muscles, so it was a good
candidate for the gene that is affected in pruned mutants. We
established that pruned1 is a loss of function mutation in the
DSRF gene by the following tests. 
First, tracheal expression of DSRF protein was indistin-
guishable from the expression pattern of the b -galactosidase
marker in embryos and third instar larvae carrying a single
copy of the pruned1 marker (compare Fig. 4A and C, and data
not shown). Expression of both DSRF and b -galactosidase was
turned on at stage 13 in all terminal cells, and expression
persisted in these cells throughout embryonic and larval life.
Second, the pruned1 mutation mapped to the DSRF locus.
The pruned1 lethality was mapped genetically to the region of
overlap (60C5-6 to 60D1-2) between chromosomal deficien-
cies Px and Px2, the same interval as DSRF (Affolter et al.,
1994). Genomic DNA flanking the pruned1 P element was then
isolated by plasmid rescue and used for molecular mapping.
The P element was inserted in the first exon of DSRF, 350 bp
upstream of the assigned translation start site (Fig. 5).
Finally, a DSRF antiserum was used to examine DSRF
protein levels in pruned1 mutants. There was no detectable
DSRF expression in the tracheal cells of mutant embryos or
larvae (Fig. 4B and data not shown). This is consistent with
the genetic data indicating that pruned1 is a null allele for the
tracheal function of the gene. DSRF protein expression in
somatic muscles of mutants was weak and difficult to detect
above background. Two of the strongest pruned alleles
(pruned1, prunedex84) were examined for muscle defects, using
an antibody to Drosophila muscle myosin. No abnormalities
were detected in the number or general organization of the
somatic musculature in homozygous or hemizygous embryos
(data not shown).
An activated SRF causes extra cytoplasmic
processes and terminal branches
Mammalian SRF is a MADS box transcription factor that
forms a complex with a subset of ETS-domain transcription
factors, called ternary complex factors, at the promoters of
immediate early genes such as c-fos. The complex is normally
inactive until the cells are exposed to various growth factors,
which trigger signaling cacades that culminate in modification
of one or more components of the complex. SRF can be made
into a constitutive activator of transcription independent of the
signaling cascades by fusion of the Herpes simplex virus VP16
transcriptional activation domain to the carboxyl terminus of
the protein (Dalton and Treisman, 1992; Fig. 6A). We tested
the effect of constitutively activated SRF on tracheal develop-
ment by expressing an SRF-VP16 chimera in developing
tracheal cells using the GAL4 indirect expression system
(Brand and Perrimon, 1993). 
Activated SRF drove formation of extra cytoplasmic
processes and terminal branches that grew out earlier than
usual and in an unregulated fashion (Fig. 6). Normally,
terminal cells like DB1 form just a single cytoplasmic projec-
tion with a single lumen by stage 17 (Fig. 3D). Embryos
expressing the activated SRF formed more and longer cyto-
plasmic extensions than normal (Fig. 6B,C). Many of these
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Fig. 3. Terminal cells in pruned mutants do not extend long cytoplasmic processes. Embryos were stained for the 1-eve-1 marker (cytoplasm in
light brown and nuclei in dark brown) and the mAb 2A12 lumenal antigen (in black). (A-D) Dorsal branch in wild-type embryos at the stages
indicated, focused in the plane of the terminal cell, DB-1. (A) Stage14, approx. 11 hours after egg lay (AEL). (B) Early stage 15, approx. 11.5
hours AEL. A short cytoplasmic projection emanates from the terminal cell (arrowhead). (C) Early stage 16, approx. 13.5 hours AEL. A short
segment of lumenal staining (arrowhead) is visible within the long thin cytoplasmic projection. (D) Stage 17 embryo, approx. 16 hours AEL.
Note bulbous ending of cytoplasmic projection (arrowhead). (E) pruned1 homozygote, stage 17. The terminal cell is present (arrowhead) but it
lacks the long cytoplasmic process seen in wild type (compare to D). (F,G) Distal portion of the pharyngeal branch of a stage 17 wild-type
embryo (F) and pruned1 homozygote (G). Cytoplasmic processes (arrowhead) are missing in the mutant. Bar, 10 m m.
A
B
C
Fig. 4. Drosophila serum response factor (DSRF) is expressed in the
same pattern as the pruned1 marker and expression is absent in
pruned mutants. (A,B) Ventrolateral views showing the tracheal
ganglionic branches of stage 17 heterozygous (A) and homozygous
(B) pruned1 embryos double stained together for DSRF (brown) and
mAb 2A12 lumenal antigen (black). DSRF staining is visible in the
nucleus (arrowhead) of terminal cells in A but not the pruned1
homozygote in B. The pruned1 homozygote has truncated terminal
branches. (C) Similar view of a pruned1 homozygote double stained
for b -galactosidase and mAb 2A12, showing the same expression of
b -galactosidase as DSRF expression in A.went on to develop a lumen, as indicated by staining with mAb
2A12 (Fig. 6D,E). Most of the extra terminal branches that
formed arose from the normal terminal cells, but other tracheal
cells sometimes formed ectopic terminal branches. These were
almost always cells adjacent to terminal cells, which
sometimes express terminal markers and form terminal
branches in wild type (Fig. 6H).
The cytoplasmic processes that formed in cells expressing
SRF-VP16 often did not grow toward their usual targets but
instead grew out in random directions, invading territories
normally supplied by other tracheal branches (Fig. 6G,H). Out-
growing branches sometimes reversed direction abruptly (Fig.
6D, arrowhead) and traversed other tracheal branches (Fig.
6E,G arrowheads), events that rarely if ever occur in wild type.
These observations demonstrate that extra cytoplasmic
outgrowth and branching can be driven by activated SRF, and
that it is independent of the normal guidance and growth
controls.
An activated ternary complex factor has similar
effects as activated SRF
In mammalian cells, SRF typically functions in conjunction
with a ternary complex factor such as Elk-1. The domain of
SRF that interacts with ternary complex factors is conserved
in the DSRF protein (Affolter et al., 1994), suggesting that such
a factor may be present in Drosophila, although none has been
identified. To test for involvement of a ternary complex factor
in terminal branching, we used constitutively activated and
dominant negative forms of mammalian Elk-1 protein. The
dominant negative form is a C-terminal truncation of Elk-1 that
removes its regulated transcriptional activation domain, so that
the protein can still interact with SRF and bind DNA but fails
to activate transcription (Hill et al., 1993; Fig. 7A). The con-
stitutively activated form of Elk-1 has the regulated transcrip-
tional activation domain replaced with the VP16 activation
domain (Hill et al., 1994; Fig. 7A). Expression of the dominant
negative Elk-1 during the period of terminal branching resulted
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Fig. 5. Molecular mapping of the pruned mutation. (A) Restriction
map of a 15 kb genomic clone containing the 5¢ portion of the
pruned/DSRF transcription unit. Positions of pruned and the
neighboring slbo (Montell et al., 1992) transcription units are shown.
Open boxes, coding sequences; filled bars, 5¢ and 3¢ untranslated
regions; diagonal lines, introns. The position of the pruned1 P
element and orientation of the P element promoter are indicated. The
1.8 kb and 6.2 kb EcoRI genomic fragments which hybridized on a
Southern blot to both the XbaI and SpeI P element rescue plasmids
are indicated by asterisks. R, EcoRI site; H, HindIII site.
(B) Nucleotide sequence of the 5¢ portion of the pruned/DSRF
transcription unit. The P element insertion site in pruned1 is shown
by the vertical line next to the eight nucleotides of genomic DNA
that were duplicated at the insertion site (boxed, nucleotides 41-48).
The first nucleotide of the DSRF cDNA sequence (nucleotide 18)
and the predicted ATG translational start (nucleotides 393-396) are
also boxed (Affolter et al., 1994). The first nucleotide shown is a
putative transcription initiation site identified by primer extension
analysis that is consistent with the length of the major pruned
transcript (2.2 kb) detected on northern blots.in truncated terminal branches very similar to those observed
in the pruned loss of function mutants (Fig. 7C). Expression
of the constitutively activated Elk-1 protein resulted in extra
terminal branches that grew out in an unregulated fashion, as
with the activated SRF protein (Fig. 7D). Although results with
Elk-1 were essentially the same as those obtained with SRF in
most respects, the extra, unregulated branching observed with
activated Elk-1 was completely dependent on the function of
the endogenous pruned gene. While pruned1 mutants express-
ing activated SRF formed rudimentary terminal branches (data
not shown), pruned1 mutants expressing activated Elk-1
displayed the pruned loss of function phenotype and did not
form terminal branches (Fig. 7E).
DISCUSSION
The Drosophila serum response factor pruned is a key
regulator of terminal branching of the tracheal system. We
have shown both that it is required for terminal branch
formation, and that an activated form of SRF is sufficient to
drive excessive terminal branching. The results further suggest
that DSRF functions like the mammalian protein, together with
a ternary complex factor. While mammalian cell culture exper-iments and in vitro studies have elucidated the mechanism of
SRF action, they cannot provide information about the process
SRF regulates in vivo. Our data show that DSRF controls cyto-
plasmic outgrowth during terminal branching, a novel function
not anticipated from previous work.
A model for DSRF function in cytoplasmic
outgrowth during terminal branching
DSRF is a structural and functional homologue of mammalian
SRF. It displays greater than 90% sequence identity with the
functional core of the mammalian protein (Affolter et al.,
1994), which includes its DNA binding, homodimerization,
and accessory protein interaction domains. The residues that
dictate binding specificity and complex formation with ternary
complex factor are completely conserved. The Drosophila
protein also has the same DNA binding specificity as the
mammalian protein (see Treisman, 1987). More compelling is
the fact that mammalian SRF derivatives can provide pruned
function in Drosophila, and a mammalian ternary complex
factor can function with DSRF. 
The close relationship between DSRF and mammalian SRF
suggests a simple molecular model for how DSRF controls
cytoplasmic outgrowth during terminal branching. Like
mammalian SRF, DSRF presumably functions as a DNA
binding transcription factor. Mammalian SRF binds and
regulates the c-fos proto-oncogene and other ‘immediate-early’
genes (Treisman, 1990). In our model, DSRF controls
expression of one or more genes that are necessary for
extension of long cytoplasmic processes from terminal cells.
Its targets might encode components necessary to form or
stabilize cytoplasmic processes, or adhesion molecules that
encourage their outgrowth.
Mammalian SRF forms a ternary complex with Elk-1 or
related ternary complex factors at the c-fos serum response
element (Treisman, 1994). Expression of dominant negative
and constitutively activated forms of Elk-1 mimicked the
pruned loss-of-function phenotype and the extra branching
phenotype of activated SRF, respectively. The effect of
activated Elk-1 required pruned+ function, as expected if
activated Elk-1 requires an SRF for binding (Shaw et al.,
1989). These results suggest that DSRF functions in the devel-
oping tracheal system with an as yet unidentified ternary
complex factor, and forms analogous ternary complexes at its
targets. 
Tracheogenic signals and the activation of the DSRF
transcription complex 
The SRF transcription complex is activated by extracellular
signals. Although the signal transduction pathways that
activate the transcription complex are still being elucidated, at
least in some instances they appear to involve Ras, Raf, and
MAP kinases, or the small Ras-like GTPases Rac, Rho, and
Cdc42, and result in the phosphorylation of one or more
proteins in the complex (reviewed by Treisman, 1995). In our
model, DSRF transcription complexes are similarly quiescent
until terminal cells receive an extracellular signal. In
mammalian cells, the signal requirement can be bypassed by
fusion of the VP16 transcriptional activation domain to either
protein of the complex, or by expression of activated forms of
Ras or other upstream signaling components, resulting in con-
stitutive expression of target genes. Expression of activated
1360 K. Guillemin and othersforms of SRF or Elk-1 in tracheal cells, or activated forms of
upstream signaling components (K. G. and M. K., unpublished
data), leads to formation of extra terminal branches that grow
out in an unregulated pattern, presumably because DSRF target
genes are constitutively expressed.
A likely source of the activating signal is the tracheal target
tissues. Experiments in other insects suggest that tracheal
targets produce a signal that induces formation of new
branches and attracts them to the target (reviewed by Manning
and Krasnow, 1993). When a target tissue is ablated during
larval development the terminal branches that normally supply
the tissue fail to form (Wigglesworth, 1954), the same conse-
quence as inactivating the pruned gene. According to our
model, both manipulations result in missing terminal branches
because in one case (target ablation) the tracheogenic signal is
removed, and in the other case (pruned mutant) the signal is
present but cannot be transduced into an effect on cytoplasmic
outgrowth. Conversely, transplantation of a metabolically
active tissue causes nearby terminal branches to proliferate and133 222 5081
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F G Hcover the tissue (Wigglesworth, 1954). Proliferation of
terminal branches is also observed in animals reared at low
oxygen pressures or other conditions that induce tissue hypoxia
(Wigglesworth, 1954; Locke, 1958). In these experiments the
oxygen-starved tissues are thought to produce increased levels
of a tracheogenic signal that causes the observed proliferation
of terminal branches, an effect that is mimicked by activated
SRF or Elk-1.
An important difference between the extra terminal branches
induced by tissue anoxia and by expression of activated SRF
or Elk-1 is seen in the outgrowth and spatial patterning of
branches. In wild type, terminal branch patterns are not stereo-
typed, but they are nevertheless highly regulated. Branches
usually remain within specific spatial domains, and they rarely
if ever cross over other tracheal branches even though they
densely cover the target. With activated SRF or Elk-1, terminal
branches grew out in various directions, invading new territo-
ries and growing over other branches. The normal mechanisms
that control the direction of cytoplasmic outgrowth and the dis-
tribution of terminal branches are apparently saturated or
bypassed by activated SRF or Elk-1. The data suggest that the
DSRF transcription complex regulates the decision to form a
new cytoplasmic extension, but not necessarily where it will
grow. There must be another mechanism, functioning in
parallel to the DSRF transcription complex, that controls where
on the cell surface the outgrowth will form and the direction it
grows.
A general role for SRF in regulation of the
cytoskeleton and cytoplasmic outgrowth?
The role of DSRF in regulating cytoplasmic outgrowth of
terminal tracheal cells is the first demonstrated function for an
SRF in an animal. Studies of mammalian SRF in cultured cellsFig. 6. Expression of an activated SRF in the tracheal system causes
extra cytoplasmic extensions and terminal branches. (A) Primary
structure of human SRF and a constitutively active derivative
containing the VP16 transcriptional activation domain. MADS box
homology and functional domains of SRF are shown. (B,C) Dorsal
branches of late stage embryos expressing SRF-VP16, double-
stained for the 1-eve-1 marker and tracheal lumen (mAb 2A12). The
DB-1 terminal cell in B and C have each formed two cytoplasmic
processes with lumen (arrowheads). The two long cytoplasmic
processes in C extend in atypical directions (compare with Fig. 3D),
as does the top process in B. (D,E) Dorsal branch of late stage
embryos expressing SRF-VP16, stained for tracheal lumen (mAb
2A12). In D, two terminal branches have formed, one of which
sharply reverses direction (arrowhead). In E, three terminal branches
have formed and one traverses another (arrowhead). (F,G) Ventral
view of right and left ganglionic branches of a control wild-type
embryo (F) and an embryo expressing SRF-VP16 (G). In G the right
(upper) ganglionic branch has formed three terminal branches and
the left (lower) ganglionic branch has formed two terminal branches,
one of which has grown across the midline over another terminal
branch (arrowhead). White arrow, ventral midline. (H) Dorsal view
of a right and left dorsal branch of an embryo expressing SRF-VP16,
stained as in B. The normal terminal cell (DB1) and an additional
cell (DB3) of the left (lower) dorsal branch have both formed long
terminal branches; the terminal branch emanating from DB1 has
inappropriately crossed the midline (white arrow). Each of these
cells has also formed a second cytoplasmic projection that traverse
one another (arrowhead). Bar (B-H), 10 m m.
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Fig. 7. Effect of dominant negative and
constitutively active forms of Elk-1 on terminal
branching. (A) Primary structure of ternary
complex factor Elk-1 and two derivatives,
showing the positions of functional domains and
three signature motifs (A, B, C) of ternary
complex factors. (B) Dorsal branch lumen of a
wild-type stage 17 embryo. Arrowhead points to
the tip of the terminal branch. (C) Stage 17
embryo expressing dominant negative Elk-1.
The terminal branch is truncated (arrowhead).
(D) Stage 17 embryo expressing Elk-1-VP16.
Three terminal branches have formed and grown
out in different directions (arrowheads).
(E) Dorsal branch lumen of a stage 17 pruned1
homozygote expressing Elk-1-VP16. The
terminal cell expresses the pruned1 marker but
does not form a terminal branch (arrowhead).
The phenotype is indistinguishable from
pruned1 homozygotes that do not express Elk-1-
VP16. Bar (B-E), 10 m m.have focused on possible roles in mitogenesis, but additional
evidence implicates SRF in regulation of the cytoskeleton. SRF
targets include a number of cytoskeletal genes (Treisman,
1995), and treatment of cells with agents that disrupt the
cytoskeleton, such as cytochalasin D, activates SRF-mediated
transcription (Zambetti et al., 1991; Hill et al., 1995). Recent
evidence has implicated SRF in signaling pathways involving
the small GTPases Rho, Rac and Cdc42 (Hill et al., 1995) that
regulate cytoskeletal rearrangements (reviewed by Chant and
Stowers, 1995; Ridley, 1995). Perhaps Rho, Rac, and Cdc42
activation of SRF stimulates expression of genes that rein-
forces the more direct effects of these small GTPases on the
cytoskeleton.
Not only does pruned regulate cytoplasmic outgrowth
during terminal branching, but it has also been found to
function during morphogenesis of the wing in a process that
also involves polarized cell shape changes (Montagne et al.,
unpublished results). One of the roles of MCM1 protein, a
related protein in yeast, is in the pheromone response pathway
in which the cell undergoes polarized cell growth (shmoo
formation) toward an extracellular signal (reviewed by Dolan
and Fields, 1991). Common to all these examples may be an
SRF homologue regulating changes in cytoskeletal compo-
nents that lead to stable alterations in cell shape.
The isolation of mutations in the pruned gene opens the way
to a detailed analysis of DSRF functions and the proposed
signaling pathway in vivo. The implication of a ternary
complex factor suggests the involvement of Ras and MAP
kinase upstream in signaling. The breathless fibroblast growth
factor receptor may also function in this pathway. Although
breathless plays crucial roles in tracheal development long
before terminal branching begins, it was recently shown that a
dominant negative form of the protein expressed late in
embryogenesis can give rise to truncated terminal branchesresembling those of the pruned loss-of-function mutants
(Reichman-Fried and Shilo, 1995).
Genetic control of branching morphogenesis:
pruned defines a regulated late program
Although tracheal branches arise sequentially from a single
homogenous cluster of tracheal precursor cells in each
hemisegment, there are morphological, molecular and func-
tional differences between early and late branching events
(Samakovlis et al., 1996). The pruned phenotype demonstrates
that the early and late branching processes are separable genet-
ically and it defines the late phase. Tracheal development thus
appears to be under the dual control of a hard-wired early
genetic program that controls the outgrowth of the stereotyped
major branches and positions them close to their targets, and a
regulated late program mediated by pruned that governs the
outgrowth of fine branches to tissues according to tissue
oxygen need. The early program also controls the highly
specific expression pattern of pruned, ensuring that only
terminal cells express pruned and are competent to respond to
signals and form terminal branches (Samakovlis et al., 1996).
There are striking morphological and functional parallels
between terminal branching and mammalian angiogenesis. It
seems likely that the system for sensing and responding to
tissue oxygen need is ancient, and it will be interesting to see
if SRF is involved in angiogenesis and if any of these parallels
extend to the molecular level.
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